

Empowering Healthcare through AI Precision and Global Integration
PRODUCTS




Strategy & Sustainability
Our
Ideology
ETAO International strategically positions itself at the forefront of the global healthcare industry, driven by advanced artificial intelligence, precise medical diagnostics, integrated digital health ecosystems, and responsible, sustainable business practices. Our clear strategic direction supports robust growth, global market leadership, and lasting value for all stakeholders.
Core Strategic Pillars

1
AI-Driven Precision Medicine
-
Leveraging advanced AI technologies to significantly enhance accuracy, reduce diagnosis time, and lower healthcare costs.
-
Proprietary algorithms designed specifically for personalized medicine, ensuring superior patient outcomes.
2
Online-Merge-Offline (OMO) Healthcare Integration
-
Seamlessly combining online digital health platforms with traditional offline healthcare services.
-
Creating a comprehensive care pathway from screening to diagnosis, treatment, and recovery.
3
Global Cross-Border Healthcare Network
-
Expertly navigating international healthcare markets (U.S., China, Canada, Latin America) to deliver compliant and effective healthcare solutions.
-
Utilizing unique cross-border collaboration frameworks to rapidly implement and scale healthcare innovations.
Mergers & Acquisitions (M&A) Strategy
ETAO’s structured approach to global mergers and acquisitions strengthens its market position and expands its healthcare capabilities.
Clear Acquisition Criteria (Five-Good Model)
Effective Integration
(Post-Merger Integration)
– PMI
-
Establishment of dedicated Integration Offices ensuring cohesive KPI management and integration execution from day one.
-
Systematic alignment of corporate governance, finance, and operational practices within 90 days post-acquisition.
-
Cultural integration programs fostering cross-border corporate cohesion and talent retention.

Financial & Operational Goals
-
Achieving significant financial scalability, with pro forma revenue projected to exceed $660M in 2025 post-integration of strategic acquisitions.
-
Positioning ETAO as a global benchmark in AI-driven healthcare, facilitating substantial market valuation enhancement upon Nasdaq relisting.
-
Clearly defined relisting timeline, targeting Nasdaq completion in Q4 2025, thereby creating significant value uplift and investment attractiveness.
ETAO aligns business objectives with global Environmental, Social, and Governance (ESG) standards, pursuing healthcare equity, environmental responsibility, and ethical governance
Social Impact Initiatives
1 / Enhancing Healthcare Accessibility
-
Extending AI-powered early cancer screening technologies to underserved populations globally.
-
Deploying remote diagnostic solutions across rural and resource-limited regions in Asia and Latin America.
2 / Bridging Healthcare Gaps
-
Innovative nurse staffing models addressing critical shortages in the United States via international training and recruitment programs.
-
Promoting telehealth and digital health platforms for widespread healthcare accessibility.
Governance and Ethical Practices
Robust Governance Framework
-
Fully compliant with SEC and Nasdaq regulations, operating transparently with clear corporate governance protocols.
-
Experienced board of directors and advisory committees actively overseeing strategic execution and compliance.
Responsible M&A Integration
-
Comprehensive due diligence ensuring ethical business integration and transparent communication to all stakeholders.
-
Regular monitoring and KPI-driven evaluations to guarantee responsible corporate growth and stable financial returns.

Environmental Stewardship
Advocating for digital transformation in healthcare delivery to significantly reduce resource consumption, waste, and environmental footprint.
Adopting sustainable operational practices within facilities, emphasizing energy efficiency, waste reduction, and sustainable resource usage.